Net profit of RPG Life Sciences rose 21.09% to Rs 26.76 crore in the quarter ended June 2024 as against Rs 22.10 crore during the previous quarter ended June 2023. Sales rose 11.94% to Rs 165.42 crore in the quarter ended June 2024 as against Rs 147.78 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales165.42147.78 12 OPM %23.6221.82 - PBDT41.2933.98 22 PBT36.0029.77 21 NP26.7622.10 21 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 19 July 2024.Powered by Capital Market - Live News

RPG Life Sciences announced that the Annual General Meeting (AGM) of the company will be held on 16 July 2024.Powered by Capital Market - Live News

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held on 30 April 2024, inter alia, have recommended the final dividend of Rs 16 per equity Share (i.e. 200%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of RPG Life Sciences rose 27.92% to Rs 13.24 crore in the quarter ended March 2024 as against Rs 10.35 crore during the previous quarter ended March 2023. Sales rose 7.17% to Rs 126.99 crore in the quarter ended March 2024 as against Rs 118.49 crore during the previous quarter ended March 2023.For the full year,net profit rose 29.60% to Rs 87.66 crore in the year ended March 2024 as against Rs 67.64 crore during the previous year ended March 2023. Sales rose 13.50% to Rs 582.05 crore in the year ended March 2024 as against Rs 512.81 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales126.99118.49 7 582.05512.81 14 OPM %16.3213.43 -22.0220.02 - PBDT22.2317.70 26 134.91107.18 26 PBT17.7413.81 28 117.8491.68 29 NP13.2410.35 28 87.6667.64 30 Powered by Capital Market - Live News